Philogen SpA (MIL:PHIL) Owner Earnings per Share (TTM): 6.40 (As of Dec. 2025) — 69% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:PHIL Philogen SpA MIL:PHIL
59 GF Score
Price €23.15
GF Value €230.73
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Philogen SpA Owner Earnings per Share (TTM)?

Philogen SpA MIL:PHIL +0.65% 59 Owner Earnings per Share (TTM) is 6.40 as of Dec. 2025, which is 69% below its 10-year median of 20.37. GuruFocus rates MIL:PHIL with a GF Score™ of 59/100 and a GF Value™ of €230.73 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 207 Biotechnology companies, Philogen SpA ranks better than 89.37% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Philogen SpA's Owner Earnings per Share (TTM) ended in Dec. 2025 was €6.40. It's Price-to-Owner-Earnings ratio for today is 3.62.


The historical rank and industry rank for Philogen SpA's Owner Earnings per Share (TTM) or its related term are showing as below:

MIL:PHIL' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.12   Med: 20.37   Max: 29.36
Current: 3.62


During the past 6 years, the highest Price-to-Owner-Earnings ratio of Philogen SpA was 29.36. The lowest was 3.12. And the median was 20.37.


MIL:PHIL's Price-to-Owner-Earnings is ranked better than
89.37% of 207 companies
in the Biotechnology industry
Industry Median: 24.92 vs MIL:PHIL: 3.62

Philogen SpA's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was €6.07. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €5.70. It's PE Ratio (TTM) ratio for today is 4.06.

Philogen SpA's EPS without NRI for the six months ended in Dec. 2025 was €6.02. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €5.62. It's PE Ratio without NRI ratio for today is 4.12.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Philogen SpA Owner Earnings per Share (TTM) Related Terms


Philogen SpA Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Philogen SpA's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Philogen SpA Owner Earnings per Share (TTM) Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial 0.00 0.00 0.00 0.92 6.40

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.92 0.00 6.40

MIL:PHIL vs VRTX, REGN, RVMD: Owner Earnings per Share (TTM) Comparison

For the Biotechnology subindustry, Philogen SpA's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Philogen SpA Price-to-Owner-Earnings vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Philogen SpA's Price-to-Owner-Earnings falls into.


MIL:PHIL
59GF Score
Philogen SpA MIL:PHIL
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Philogen SpA Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Philogen SpA's Owner Earnings per Share (TTM) Calculation:

Last Year Average of Last 5 Years
Net Income 229.7
Depreciation, Depletion and Amortization 4.3
Change In Deferred Tax 30.4
5Y Average of Maintenance Capital Expenditure 4.6
Change In Working Capital -2.2
Shares Outstanding (Diluted Average) 40.3

1. Start with "Net Income" from income statement. Philogen SpA's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was €229.7 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Philogen SpA's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Dec. 2025 was €4.3 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Philogen SpA's Change In Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2025 was €30.4 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = €4.6 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Philogen SpA's 5-Year Average Maintenance Capital Expenditure = €4.6 Mil

5. "Change In Working Capital" is from cashflow statement. Philogen SpA's Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.2 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Philogen SpA's Shares Outstanding (Diluted Average) for the months ended in Dec. 2025 was 40.275 Mil.

Philogen SpA's Onwer Earnings Per Share for Dec. 2025 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 229.676 +4.256+30.432
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-4.5878+-2.205)/40.275
=6.40

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=23.15/6.40
=3.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 6.40 mean?
Philogen SpA (MIL:PHIL) has a Owner Earnings per Share (TTM) of 6.40 as of Dec. 2025. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Philogen SpA. This is 69% below median its historical median of 20.37. Over the past decade, Philogen SpA's Owner Earnings per Share (TTM) has ranged from 3.12 to 29.36. According to the industry distribution chart, Philogen SpA ranks #22 out of 207 companies in the Biotechnology industry, placing it in the top 10.6%.
Is Philogen SpA's Owner Earnings per Share (TTM) too high?
Philogen SpA's current Owner Earnings per Share (TTM) of 6.40 is 69% below median its 10-year median of 20.37. Over the past 10 years, this metric has ranged from a low of 3.12 to a high of 29.36. The Biotechnology industry median Owner Earnings per Share (TTM) is 24.92. Philogen SpA's value of 6.40 is 74.3% below this industry median. Based on the distribution chart, Philogen SpA ranks #22 out of 207 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Philogen SpA has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Philogen SpA's Owner Earnings per Share (TTM) compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Philogen SpA ranks #22 out of 207 companies for Owner Earnings per Share (TTM). This places Philogen SpA in the top 11% of its industry — outperforming the majority of peers. The industry median Owner Earnings per Share (TTM) is 24.92. Philogen SpA's value of 6.40 is 74.3% below this benchmark. Historically, Philogen SpA's own Owner Earnings per Share (TTM) has ranged from 3.12 to 29.36 over the past decade. While the company's 10-year median is 20.37 vs. the industry median of 24.92, Philogen SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Biotechnology company?
The median Owner Earnings per Share (TTM) among Biotechnology companies is 24.92, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Philogen SpA's current Owner Earnings per Share (TTM) of 6.40 is 74.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Philogen SpA. For the Biotechnology industry, the median Owner Earnings per Share (TTM) is 24.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Philogen SpA's current Owner Earnings per Share (TTM) is 6.40, which is 69% below median its own 10-year median of 20.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Philogen SpA stock overvalued right now?
Based on GuruFocus' analysis, Philogen SpA (MIL:PHIL) is currently considered Possible Value Trap. The stock's GF Value™ is €230.73, compared to a current price of €23.15 — trading 90% below its estimated fair value. The current Owner Earnings per Share (TTM) is 6.40, which is 69% below median its 10-year median of 20.37 and 74.3% below the Biotechnology industry median of 24.92. Philogen SpA's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Philogen SpA (MIL:PHIL), the current Owner Earnings per Share (TTM) is 6.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Philogen SpA (MIL:PHIL) Overvalued in 2026?

Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued. The current stock price of €23.15 is trading 90% below its estimated GF Value™ of €230.73. GuruFocus considers Philogen SpA to be Possible Value Trap.

Key valuation signals for MIL:PHIL:

  • Owner Earnings per Share (TTM): 6.40 (69% below median its 10-year median of 20.37)
  • GF Value™: €230.73 vs. price of €23.15 (90% below fair value)
  • GF Score™: 59/100 with 3 warning signs
  • Industry Position: 74.3% below the Biotechnology median (#22 of 207)

No single metric tells the full story. See the MIL:PHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Philogen SpA Business Description

Other Exchanges 78Q:Germany
Address Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
59GF Score

Get the complete analysis for MIL:PHIL

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.15
Price
€230.73
GF Value